Lobeline, a nicotinic partial agonist attenuates alcohol consumption and preference in male C57BL/6J mice

Physiology and Behavior

Volumn 97, Issue 3-4, 2009, Pages 503-506

  Farook, Justin M ^a   Lewis, Ben ^a   Gaddis, Justin G ^a   Littleton, John M ^a   Barron, Susan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acetylcholine receptors; Alcohol; C57BL 6J mice; Consumption; Nicotine

Indexed keywords

LOBELINE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; FLUID INTAKE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASTE PREFERENCE;

ALCOHOL DRINKING; ANALYSIS OF VARIANCE; ANIMALS; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FOOD PREFERENCES; LOBELINE; MALE; MICE; MICE, INBRED C57BL; NICOTINIC AGONISTS;

EID: 67349156699     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2009.02.031     Document Type: Article

References (33)

1. Littleton J., Barron S., Prendergast M., and Nixon S.J. Smoking kills (alcoholics)! Shouldn't we do something about it?. Alcohol Alcohol. 42 (2007) 167-173
2. Wickholm S., Galanti M.R., Söder B., and Gilljam H. Cigarette smoking, snuff use and alcohol drinking: coexisting risk behaviours for oral health in young males. Community Dent Oral Epidemiol 31 (2003) 269-274
3. Rose J.E., Brauer L.H., Behm F.M., Cramblett M., Calkins K., and Lawhon D. Psychopharmacological interactions between nicotine and ethanol. Nicotine Tob Res 6 (2004) 133-144
4. NIAAA: National Institute of Alcohol Abuse and Alcoholism. Alcohol Alert, No. 39 (January): Alcohol and Tobacco. 1998; No. 39 (January). http://www.niaaa.nih.gov.
5. Drobes D.J. NIAAA: National Institute of Alcohol Abuse and Alcoholism. Alcohol and comorbid mental health disorders. Alcohol Res Health 26 2 (2002) 136-142
6. Blomqvist O., Engel J.A., Nissbrandt H., and Soderpalm B. The mesolimbic dopamineactivating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol 249 (1993) 207-213
7. Soderpalm B., Ericson M., Olausson P., Blomqvist O., and Engel J.A. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113 (2000) 85-96
8. Wonnacott S., Sidhpura N., and Balfour D.J.K. Nicotine: from molecular mechanisms to behaviour. Curr Opin Pharmacol 5 (2005) 53-59
9. Owens J.C., Balogh S.A., McClure-Begley T.D., Butt C.M., Labarca C., Lester H.A., Picciotto M.R., Wehner J.M., and Collins A.C. Alpha 4 beta 2* nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. Alcohol Clin Exp Res 27 (2003) 1867-1875
10. Gauvin D.V., Moore K.R., and Holloway F.A. Do rat strain differences in ethanol consumption reflect differences in ethanol sensitivity or the preparedness to learn?. Alcohol 10 (1993) 37-43
11. Ericson M., Molander A., Löf E., Engel J.A., and Söderpalm B. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors. Eur J Pharmacol 467 (2003) 85-93
12. Damaj M.I., Patrick G.S., Creasy K.R., and Martin B.R. Pharmacology of lobeline, a nicotinic receptor ligand. J Pharmacol Exp Ther 282 (1997) 410-419
13. Miller D.K., Harrod S.B., Green T.A., Wong M.Y., Bardo M.T., and Dwoskin L.P. Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats. Pharmacol Biochem Behav 74 (2003) 279-286
14. Buchhalter A.R., Fant R.V., and Henningfield J.E. Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status. Drugs 68 (2008) 1067-1088
15. Neugebauer N.M., Harrod S.B., Stairs D.J., Crooks P.A., Dwoskin L.P., and Bardo M.T. Lobelane decreases methamphetamine self-administration in rats. Eur J Pharmacol 571 (2007) 33-38
16. Polston J.E., Cunningham C.S., Rodvelt K.R., and Miller D.K. Lobeline augments and inhibits cocaine-induced hyperactivity in rats. Life Sci 79 (2006) 981-990
17. Yoneyama N., Crabbe J.C., Ford M.M., Murillo A., and Finn D.A. Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42 (2008) 149-160
18. Farook J.M., Lewis B., Littleton J.M., and Barron S. Topiramate attenuates the stress-induced increase in alcohol consumption and preference in male C57BL/6J mice. Physiol Behav. 96 (2009) 189-193
19. Cunningham C.S., Polston J.E., Jany J.R., Segert I.L., and Miller D.K. Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine. Drug Alcohol Depend 84 (2006) 211-222
20. Yoshimoto K., McBride W.J., Lumeng L., and Li T.K. Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats. Alcohol Clin Exp Res 16 (1992) 781-785
21. Koob G.F. Hedonic valence, dopamine and motivation. Mol Psychiatry 1 (1996) 186-189
22. Wellman P.J., Elliott A.E., Barbee S., Hollas C.N., Clifford P.S., and Nation J.R. Lobeline attenuates progressive ratio breakpoint scores for intracranial self-stimulation in rats. Physiol Behav. 18 (2008) 952-957
23. Miller D.K. Review of research on lobeline, a potential pharmacotherapy for methamphetamine abuse. In: Toolaney G.R. (Ed). New research on methamphetamine abuse (2006), Nova Science Publishers, Hauppauge, New York
24. Klink R., de Kerchove d'Exaerde A., Zoli M., and Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21 (2001) 1452-1463
25. Wooltorton J.R., Pidoplichko V.I., Broide R.S., and Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23 (2003) 3176-3185
26. Lecca D., Shim I., Costa E., and Javaid J.I. Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats. Neuropharmacology 39 (2000) 88-98
27. Brioni J.D., Decker M.W., Sullivan J.P., and Arneric S.P. The pharmacology of (-) nicotine and novel cholinergic channel modulators. Advances in Pharmacology 17 (1997) 153-214
28. Decker M.W., Buckley M.J., and Brioni J.D. Differential effects of pretreatment with nicotine and lobeline on nicotine-induced changes in body temperature and locomotor activity in mice. Drug Dev Res 31 (1994) 52-58
29. Brioni J.D., and Arneric S.P. Nicotine receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav Neural Bio 59 (1993) 57-62
30. Decker M.W., Brioni J.D., Bannon A.W., and Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci 56 (1995) 545-570
31. Bhat R.V., Turner S.L., Selvaag S.R., Marks M.J., and Collins A.C. Regulation of brain nicotinic receptors by chronic infusion. J Neurochem 56 (1991) 1932-1939
32. Butt C.M., King N.M., Stitzel J.A., and Collins A.C. Interaction of the nicotinic cholinergic system with ethanol withdrawal. J Pharmacol Exp Ther 308 (2004) 591-599
33. Wehner J.M., Keller J.J., Keller A.B., Picciotto M.R., Paylor R., Booker T.K., Beaudet A., Heinemann S.F., and Balogh S.A. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience 129 (2004) 11-24